INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Communiqués Integra LifeSciences Holdings Corporation

Actions

IART

US4579852082

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
30,9 ^USD	+0,32 %		+9,15 %	-29,05 %

24/05	Un initié d'Integra Lifesciences Holdings a acheté des actions d'une valeur de 1 499 979 $, selon un récent dépôt auprès de la SEC	MT
22/05	Un initié d'Integra Lifesciences Holdings a acheté des actions d'une valeur de 995 816 $, selon un récent dépôt auprès de la SEC	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference	13/05	AQ
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024	06/05	AQ
Integra LifeSciences : Asian American & Pacific Islander (AAPI) Heritage Month – Advancing Leaders Through Innovation	06/05	PU
Integra: Q1 Earnings Snapshot	06/05	AQ
Integra LifeSciences Reports First Quarter 2024 Financial Results	06/05	AQ
Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting	30/04	AQ
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024	18/04	AQ
Integra LifeSciences : 46 Years of Creating Magnificent Instruments	18/04	PU
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.	01/04	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART	25/03	PR
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases	11/03	AQ
Integra: Q4 Earnings Snapshot	28/02	AQ
Integra LifeSciences Announces Leadership Transition Plan	28/02	AQ
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance	28/02	AQ
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024	07/02	AQ
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	05/01	AQ
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®	13/12	AQ
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors	12/12	AQ
Integra LifeSciences : Piper Sandler Healthcare Conference	28/11	PU
INTEGRA FINAL DEADLINE ALERT	13/11	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Integra LifeSciences Holdings Corporation

Actions

IART

US4579852082

Communiqués

Filtres